Status:
COMPLETED
Treat-to-target in RA: Collaboration To Improve adOption and adhereNce
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine if a Learning Collaborative is an effective tool to improve adoption and adherence to a Treat-to-Target (TTT) treatment strategy in U.S. rheumatology practice...
Detailed Description
Twelve rheumatology practices around the U.S. will be recruited to participate in a Learning Collaborative (LC). Eligible practices will have at least 50 rheumatoid arthritis patients, at least 2 rheu...
Eligibility Criteria
Inclusion
- rheumatology practices with at least 50 RA patients for the practice
- rheumatology practices with at least 2 rheumatologists
- rheumatology practices utilizing an electronic medical record or typed notes
Exclusion
- rheumatology practices already explicitly employing Treat-to-target principles
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT02260778
Start Date
September 1 2014
End Date
July 1 2024
Last Update
August 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.